BIB vs. CDE
BIB (ProShares Ultra Nasdaq Biotechnology) is Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%), while CDE (Coeur Mining, Inc.) is a stock. Over the past 10 years, BIB returned 6.70%/yr vs 0.05%/yr for CDE. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
BIB vs. CDE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIB achieves a 20.44% return, which is significantly higher than CDE's -12.63% return. Over the past 10 years, BIB has outperformed CDE with an annualized return of 6.70%, while CDE has yielded a comparatively lower 0.05% annualized return.
BIB
- 1D
- -0.55%
- 1M
- -10.07%
- 6M
- 13.09%
- YTD
- 20.44%
- 1Y
- 89.25%
- 3Y*
- 24.35%
- 5Y*
- -1.15%
- 10Y*
- 6.70%
- ALL TIME*
- 17.23%
CDE
- 1D
- 4.36%
- 1M
- -10.06%
- 6M
- -23.34%
- YTD
- -12.63%
- 1Y
- 79.46%
- 3Y*
- 78.04%
- 5Y*
- 17.59%
- 10Y*
- 0.05%
- ALL TIME*
- -7.40%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $598.53K | $1.01M | $971.81K | |
| $540.35M | $426.26M | $545.43M |
BIB vs. CDE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 20.44% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
CDE Coeur Mining, Inc. | -12.63% | 211.71% | 75.46% | -2.98% | -33.33% | -51.30% | 28.09% | 80.76% | -40.40% | -17.49% |
Correlation
The correlation between BIB and CDE is 0.27, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.27 |
Correlation (3Y) Balances recent behavior with more history. | 0.27 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.28 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.25 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.23 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIB vs. CDE — Risk / Return Rank
BIB
CDE
BIB vs. CDE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and Coeur Mining, Inc. (CDE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIB | CDE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.13 | ||
| Sortino ratioReturn per unit of downside risk | +1.09 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.22 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 5.30 | 1.67 | +3.63 |
| Martin ratioReturn relative to average drawdown | 14.80 | 3.02 | +11.78 |
Loading charts...
Drawdowns
BIB vs. CDE - Drawdown Comparison
The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum CDE drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for BIB and CDE.
Loading charts...
Drawdown Indicators
| BIB | CDE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.24% | -99.40% | +32.16% |
Max Drawdown (1Y)Largest decline over 1 year | -16.92% | -47.79% | +30.87% |
Max Drawdown (3Y)Largest decline over 3 years | -45.30% | -47.79% | +2.49% |
Max Drawdown (5Y)Largest decline over 5 years | -65.86% | -72.43% | +6.57% |
Max Drawdown (10Y)Largest decline over 10 years | -66.20% | -87.42% | +21.22% |
Current DrawdownCurrent decline from peak | -12.53% | -94.60% | +82.07% |
Average DrawdownAverage peak-to-trough decline | -32.54% | -81.54% | +49.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.05% | 26.43% | -20.38% |
Volatility
BIB vs. CDE - Volatility Comparison
The current volatility for ProShares Ultra Nasdaq Biotechnology (BIB) is 10.35%, while Coeur Mining, Inc. (CDE) has a volatility of 18.23%. This indicates that BIB experiences smaller price fluctuations and is considered to be less risky than CDE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIB | CDE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.35% | 18.23% | -7.88% |
Volatility (6M)Calculated over the trailing 6-month period | 31.34% | 52.28% | -20.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.61% | 73.54% | -32.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.69% | 68.81% | -25.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.30% | 68.86% | -22.56% |
Dividends
BIB vs. CDE - Dividend Comparison
BIB's dividend yield for the trailing twelve months is around 0.34%, more than CDE's 0.13% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.34% | 0.77% | 1.69% | 0.07% | 0.03% |
CDE Coeur Mining, Inc. | 0.13% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIB and CDE have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CDE has higher volatility (18.23%) compared to BIB (10.35%). In terms of maximum drawdown, BIB dropped -67.24% vs CDE's -99.40%.
BIB currently has the higher Sharpe Ratio (2.21 vs 1.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIB and CDE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer